DINA GLUCK: Open Payments
NPI 1851762504 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,868 in 77 payments from 19 companies in 2025. Trend: 2023 $1,329 · 2024 $1,542 · 2025 $1,868
Food & beverage: $1,768Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $252 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $235 |
| UCB, Inc. | 9 | $193 |
| Regeneron Healthcare Solutions, Inc. | 6 | $183 |
| Incyte Corporation | 8 | $171 |
| Janssen Biotech, Inc. | 4 | $169 |
| Arcutis Biotherapeutics, Inc. | 5 | $100 |
| GENZYME CORPORATION | 3 | $95 |
| ABBVIE INC. | 5 | $94 |
| Galderma Laboratories, L.P. | 4 | $62 |
Products named: DUPIXENT, Bimzelx, COSENTYX, OPZELURA, TREMFYA, Leqselvi, Zoryve, RINVOQ.
Industry payments across TN — which companies pay providers there.
